The following two issues were investigated: a) comparison of gene expression in prostate cancer tissues and benign prostate tissues; and b) comparison of gene expression in ERG rearrangement-positive (ERG+) and ERG rearrangement-negative (ERG−) prostate cancers (study plan in Figure 1). This evidence concerns the gene ERG and prostate cancer.